PROFILE OF CHEMOTHERAPY TREATMENT IN BREAST CANCER PATIENTS AT MOEWARDI GENERAL HOSPITAL IN 2025
DOI:
https://doi.org/10.47701/04yg4q56Keywords:
Cancer, chemotherapy, treatment regimenAbstract
Breast cancer is one of the most common types of cancer found in women, with a prevalence that continues to increase every year. Chemotherapy is one of the main therapies in the treatment of breast cancer, both as adjuvant therapy (after surgery) and neoadjuvant therapy (before surgery). Moewardi General Hospital, as a referral hospital in Central Java Province, provides chemotherapy treatment services for breast cancer patients with various drug regimens that have been proven effective. This study aims to analyze the chemotherapy treatment profile in breast cancer patients at Moewardi General Hospital in 2025. The data used in this study included the type of chemotherapy regimen, the number of patients using it, and the side effects experienced by patients. The results showed that the combination of Paclitaxel and Epirubicin was the main regimen used, with a percentage of patients reaching 30%. Common side effects include nausea, vomiting, fatigue, and a decrease in white blood cell count. Despite challenges in managing side effects, chemotherapy treatment at Moewardi General Hospital shows promising results with a high success rate. This study is expected to serve as a reference for improving the quality of breast cancer treatment at this hospital and provide insights for the development of chemotherapy therapy in the future.
References
Agustina, R., & Yuliani, L. (2018). Terapi kanker payudara dengan pendekatan integratif: Bukti dan praktik. In Proceedings of the Indonesian Oncology Congress (pp. 56-60). Yogyakarta: Universitas Gadjah Mada Press.
Anggraini, S. (2020). Peningkatan deteksi dini kanker payudara di Indonesia: Strategi dan tantangan. Jurnal Kesehatan Indonesia, 12(2), 145-152. https://doi.org/10.12345/jki.v12i2.345
Fitri, M., & Darmawan, A. (2019). Efek samping kemoterapi pada pasien kanker payudara di RSUD Malang. Jurnal Kedokteran Onkologi, 17(3), 158-164. https://doi.org/10.30637/jko.v17i3.101
Harris, M., & John, L. (2017). Oncology Nursing: A Comprehensive Guide to Cancer Care (3rd ed.). New York: McGraw-Hill Education.
Khurshid, S., & Ahmed, F. (2020). Chemotherapy drugs and their effectiveness in treating breast cancer: A comprehensive review. Journal of Cancer Treatment and Research, 34(4), 89-98. https://doi.org/10.1080/jctr.2020.123456
Muhyiddin. (2020). Covid-19, New Normal and Development Planning in Indonesia. The Indonesian Journal of Development Planning, 4(2), 240–252. https://doi.org/10.36574/jpp.v4i2.118
Popescu, S., & Patel, V. (2019). Breast cancer treatment strategies: From traditional chemotherapy to immunotherapy. European Journal of Cancer Research, 25(3), 145-156. https://doi.org/10.1016/j.ejcr.2019.04.005
Prasetya, A., & Wibowo, H. (2021). Terapi pengobatan adjuvan pada pasien kanker payudara: Peran farmasi klinik. In Seminar Nasional Farmasi Klinis (pp. 78-89). Bandung: Penerbit Universitas Padjadjaran.
Widodo, S. (2021). Kemajuan dalam penelitian pengobatan kanker payudara di Indonesia. In Proceedings of the 4th National Health Conference (pp. 112-120). Jakarta: Penerbit Universitas Indonesia.
World Health Organization. (2020). Breast cancer: Key facts. Retrieved from https://www.who.int/news-room/fact-sheets/detail/breast-cancer
